Items where authors include "Elliott, D.J."

Article

Siachisumo, C., Luzzi, S. orcid.org/0000-0001-6337-7495, Aldalaqan, S. et al. (14 more authors) (2024) An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression. eLife, 12. ISSN 2050-084X

Goode, E.A., Orozco-Moreno, M. orcid.org/0000-0002-6180-7882, Hodgson, K. orcid.org/0000-0003-4348-0430 et al. (10 more authors) (2024) Sialylation inhibition can partially revert acquired resistance to enzalutamide in prostate cancer cells. Cancers, 16 (17). 2953. ISSN 2072-6694

Hodgson, K., Orozco-Moreno, M. orcid.org/0000-0002-6180-7882, Goode, E.A. et al. (29 more authors) (2024) Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone. eBioMedicine, 104. 105163. ISSN 2352-3964

Atkinson, R., Georgiou, M., Yang, C. et al. (29 more authors) (2024) PRPF8-mediated dysregulation of hBrr2 helicase disrupts human spliceosome kinetics and 5´-splice-site selection causing tissue-specific defects. Nature Communications, 15 (1). 3138. ISSN 2041-1723

Hodgson, K., Orozco-Moreno, M., Scott, E. et al. (15 more authors) (2023) The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer. Scientific Reports, 13. 17031. ISSN 2045-2322

Scott, E. orcid.org/0000-0002-5358-5132, Archer Goode, E., Garnham, R. et al. (39 more authors) (2023) ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. The Journal of Pathology, 261 (1). pp. 71-84. ISSN 0022-3417

Green, D. orcid.org/0000-0002-0217-3322, Singh, A., Tippett, V.L. et al. (13 more authors) (2023) YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522. Journal of Bone Oncology, 39. 100474. ISSN 2212-1374

Scott, E., Hodgson, K., Calle, B. orcid.org/0000-0002-9893-9803 et al. (56 more authors) (2023) Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth. Oncogene, 42. pp. 926-937. ISSN 0950-9232